CRSPCRISPR Therapeutics AG
$53.41-14% 1Y
$53.41
$44.3452 weeks$76.78
Latest close: back above its 200-day averageOct 9, 2026what changed →
Is it growing?
Watch
2 to watch, 1 without dataGrowth is fading: revenue shrinking (−89% year on year) and operating margin narrowing (−629.6 points).
Revenue trend−89% in a year
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −10% a year.
Margin direction−629.6 points operating
Trailing-twelve-month operating margin, -16852.4% now against -16222.8% a year earlier.
All from SEC EDGAR, as of Mar 31, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Biotechnology
The closest names by size in the same industry